Toru Tanaka

National Hospital Organization — Japan

Engineering · Physical Sciences

35h-index5.6kcitations300works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced DC-DC Converters(22), Blood Pressure and Hypertension Studies(21), Hepatitis B Virus Studies(19), Hepatitis C virus research(18), Cardiovascular Health and Disease Prevention(18)

Publications291 total

Figure 1 from ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer
2026Open Access
Supplementary Table S1 from ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer
2026Open Access
Supplementary Figure S5 from ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer
2026Open Access
Supplementary Figure S4 from ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer
2026Open Access
Figure 5 from ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer
2026Open Access
Figure 3 from ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer
2026Open Access
Supplementary Table S2 from ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer
2026Open Access
Supplementary Figure S6 from ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer
2026Open Access
Supplementary Figure S7 from ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer
2026Open Access
Supplementary Figure S1 from ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer
2026Open Access
Figure 6 from ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer
2026Open Access
Figure 4 from ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer
2026Open Access
Table 2 from ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer
2026Open Access
Cushing’s syndrome with diabetes insipidus in pregnancy: a case report
BMC Endocrine Disorders·2025· 1 citedOpen Access
Optimal dose of maintenance steroid therapy for relapse of chronic eosinophilic pneumonia: a multicentre retrospective study
BMJ Open Respiratory Research·2025Open Access
Cushing’s syndrome with diabetes insipidus in Pregnancy: a case report
2025Open Access
Non-inferiority of sodium zirconium cyclosilicate versus potassium-restricted diet in achieving normokalaemia in patients with type 2 diabetes mellitus: protocol for a multicentre, open-label, randomised controlled, two-arm clinical trial (SILVERSTAR study)
BMJ Open·2025Open Access
Fully automatic fossa ovalis segmentation from computed tomography images using deep neural network with atlas-based localization
Informatics in Medicine Unlocked·2025Open Access
A Method for the Short-Circuit Protection of an Outdoor DC Power Bus Wiring System
IEEJ Transactions on Power and Energy·2024
C-C chemokine receptor 4 deficiency exacerbates early atherosclerosis in mice
2024Open Access
page 1 of 15Next →

Frequent Co-authors

Hiroaki Okamoto(8), Kenichi Sekiguchi(7), Y. Miyakawa(6), Fumio Tsuda(5), Ryozo Nagai(5), Masahiko Kurabayashi(4), Masashi Arai(4), A Machida(4), Y. Akahane(3), Fumio Tsuda(3), M Mayumi(3), Kazuo Kiguchi(3), Toshio Fukuda(3), Makoto Mayumi(3), Yasushi Aihara(3), Tomoyuki Yokoyama(3), Akira Yoshikawa(3), Satoru Tani(3), Yoshiki Sugai(2), Koei Sato(2)